JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 2 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.45B |
| 3 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.34B |
| 4 |
EA
Electronic Arts
EA
|
+$903M |
| 5 |
Automatic Data Processing
ADP
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.63B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.06B |
| 3 |
Meta Platforms (Facebook)
META
|
+$942M |
| 4 |
Nike
NKE
|
+$779M |
| 5 |
Union Pacific
UNP
|
+$543M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.17% |
| 2 | Technology | 12.62% |
| 3 | Healthcare | 10.37% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GHL
2651
DELISTED
Greenhill & Co., Inc.
GHL
| $4.85M | ﹤0.01% |
184,201
-204,961
| -53% | -$6.08M |
|
2652
CALL
BioMarin Pharmaceuticals
BMRN
$13.1B
| $4.85M | ﹤0.01% |
50,000
-44,000
| -47% | -$4.39M |
|
2653
Teekay
TK
$1.09B
| $4.85M | ﹤0.01% |
719,012
+144,043
| +25% | +$995K |
|
2654
Interface
TILE
$2.2B
| $4.84M | ﹤0.01% |
207,291
-32,446
| -14% | -$753K |
|
2655
Iovance Biotherapeutics
IOVA
$2.94B
| $4.82M | ﹤0.01% |
428,232
-7,654
| -2% | -$109K |
|
2656
PUT
Skyworks Solutions
SWKS
$10.4B
| $4.82M | ﹤0.01% |
53,100
| – | – |
|
|
INN
2657
Summit Hotel Properties
INN
$656M
| $4.82M | ﹤0.01% |
355,889
-803,993
| -69% | -$11.1M |
|
2658
CALL
Philip Morris
PM
$297B
| $4.81M | ﹤0.01% |
59,000
-70,300
| -54% | -$5.77M |
|
2659
Uranium Energy
UEC
$5.62B
| $4.81M | ﹤0.01% |
2,796,077
-325,186
| -10% | -$541K |
|
2660
BWX Technologies
BWXT
$15.8B
| $4.81M | ﹤0.01% |
76,876
-24,818
| -24% | -$1.57M |
|
2661
iShares MBS ETF
MBB
$39.1B
| $4.79M | ﹤0.01% |
46,327
+8,875
| +24% | +$921K |
|
|
UBA
2662
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $4.78M | ﹤0.01% |
224,501
+18,797
| +9% | +$415K |
|
2663
PUT
Tyson Foods
TSN
$20.5B
| $4.76M | ﹤0.01% |
80,000
| – | – |
|
2664
CALL
Akamai
AKAM
$18B
| $4.75M | ﹤0.01% |
65,000
| – | – |
|
|
2665
PUT
Akamai
AKAM
$18B
| $4.75M | ﹤0.01% |
65,000
| – | – |
|
|
BNY
2666
PUT
Bank of New York Mellon
BNY
$110B
| $4.75M | ﹤0.01% |
93,100
| – | – |
|
|
CSGS
2667
DELISTED
CSG Systems International
CSGS
| $4.75M | ﹤0.01% |
118,181
-33,042
| -22% | -$1.31M |
|
2668
Encore Capital Group
ECPG
$2.17B
| $4.75M | ﹤0.01% |
132,356
+71,722
| +118% | +$2.72M |
|
|
SPN
2669
DELISTED
Superior Energy Services, Inc.
SPN
| $4.71M | ﹤0.01% |
48,407
-1,033
| -2% | -$97K |
|
2670
ProShares Russell 2000 Dividend Growers ETF
SMDV
$709M
| $4.71M | ﹤0.01% |
80,067
+2,283
| +3% | +$134K |
|
|
ITCI
2671
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4.71M | ﹤0.01% |
217,232
-39,263
| -15% | -$821K |
|
2672
Enanta Pharmaceuticals
ENTA
$380M
| $4.71M | ﹤0.01% |
55,059
-13,414
| -20% | -$1.34M |
|
|
WBT
2673
DELISTED
Welbilt, Inc.
WBT
| $4.7M | ﹤0.01% |
225,323
+39,538
| +21% | +$871K |
|
|
CWEN.A
2674
DELISTED
Clearway Energy Class A
CWEN.A
| $4.7M | ﹤0.01% |
246,669
+71,358
| +41% | +$1.35M |
|
|
SYKE
2675
DELISTED
SYKES Enterprises Inc
SYKE
| $4.69M | ﹤0.01% |
153,845
-282,899
| -65% | -$8.44M |
|
Similar funds
JP Morgan Chase's Q3 2018 Portfolio in Review
As of Q3 2018, JP Morgan Chase held 6,019 positions worth $522B, up 7.4% from $486B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2018 filing shows 449 new, 2,597 increased, 2,100 reduced and 313 closed positions. Its largest new stake was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B. The largest sale was Broadcom, an estimated $1.63B.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2018 buy was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Japan ETF in Q3 2018, an estimated $1.83B increase.
- JP Morgan Chase's biggest Q3 2018 reduction was Broadcom, cutting an estimated $1.63B.
- JP Morgan Chase fully exited Cavium, Inc. in Q3 2018, selling an estimated $316M.
- JP Morgan Chase's ten largest holdings make up 18% of its $522B portfolio in Q3 2018.
- JP Morgan Chase opened 449 new positions and closed 313 in Q3 2018.
- JP Morgan Chase's portfolio value rose 7.4% quarter-over-quarter to $522B.
Based on JP Morgan Chase's 13F filing for Q3 2018, filed 7 Nov 2018.